Literature DB >> 24574402

A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.

Kentaro Yoshii1, Yuji Sunden, Kana Yokozawa, Manabu Igarashi, Hiroaki Kariwa, Michael R Holbrook, Ikuo Takashima.   

Abstract

UNLABELLED: Tick-borne encephalitis virus (TBEV) and Omsk hemorrhagic fever virus (OHFV) are highly pathogenic tick-borne flaviviruses; TBEV causes neurological disease in humans, while OHFV causes a disease typically identified with hemorrhagic fever. Although TBEV and OHFV are closely related genetically, the viral determinants responsible for these distinct disease phenotypes have not been identified. In this study, chimeric viruses incorporating components of TBEV and OHFV were generated using infectious clone technology, and their pathological characteristics were analyzed in a mouse model to identify virus-specific determinants of disease. We found that only four amino acids near the C terminus of the NS5 protein were primarily responsible for the development of neurological disease. Mutation of these four amino acids had no effect on viral replication or histopathological features, including inflammatory responses, in mice. These findings suggest a critical role for NS5 in stimulating neuronal dysfunction and degeneration following TBEV infection and provide new insights into the molecular mechanisms underlying the pathogenesis of tick-borne flaviviruses. IMPORTANCE: Tick-borne encephalitis virus (TBEV) and Omsk hemorrhagic fever virus (OHFV) belong to the tick-borne encephalitis serocomplex, genus Flavivirus, family Flaviviridae. Although TBEV causes neurological disease in humans while OHFV causes a disease typically identified with hemorrhagic fever. In this study, we investigated the viral determinants responsible for the different disease phenotypes using reverse genetics technology. We identified a cluster of only four amino acids in nonstructural protein 5 primarily involved in the development of neurological disease in a mouse model. Moreover, the effect of these four amino acids was independent of viral replication property and did not affect the formation of virus-induced lesions in the brain directly. These data suggest that these amino acids may be involved in the induction of neuronal dysfunction and degeneration in virus-infected neurons, ultimately leading to the neurological disease phenotype. These findings provide new insight into the molecular mechanisms of tick-borne flavivirus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574402      PMCID: PMC4019083          DOI: 10.1128/JVI.00421-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The 37-amino-acid interdomain of dengue virus NS5 protein contains a functional NLS and inhibitory CK2 site.

Authors:  J K Forwood; A Brooks; L J Briggs; C Y Xiao; D A Jans; S G Vasudevan
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

Review 2.  PDZ domain proteins of synapses.

Authors:  Eunjoon Kim; Morgan Sheng
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

3.  Single point mutation in tick-borne encephalitis virus prM protein induces a reduction of virus particle secretion.

Authors:  Kentarou Yoshii; Akihiro Konno; Akiko Goto; Junko Nio; Mayumi Obara; Tomotaka Ueki; Daisuke Hayasaka; Tetsuya Mizutani; Hiroaki Kariwa; Ikuo Takashima
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

Review 4.  Flavivirus genome organization, expression, and replication.

Authors:  T J Chambers; C S Hahn; R Galler; C M Rice
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

5.  Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences.

Authors:  V Proutski; E A Gould; E C Holmes
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

6.  An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus.

Authors:  Michael R Holbrook; Judith F Aronson; Gerald A Campbell; Steven Jones; Heinz Feldmann; Alan D T Barrett
Journal:  J Infect Dis       Date:  2004-12-03       Impact factor: 5.226

7.  Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs.

Authors:  T S Gritsun; K Venugopal; P M Zanotto; M V Mikhailov; A A Sall; E C Holmes; I Polkinghorne; T V Frolova; V V Pogodina; V A Lashkevich; E A Gould
Journal:  Virus Res       Date:  1997-05       Impact factor: 3.303

8.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

9.  Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and lambda 2 protein of reovirus.

Authors:  E V Koonin
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

10.  Axonal degeneration and regeneration in sensory roots in a genital herpes model.

Authors:  D Soffer; J R Martin
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

View more
  12 in total

1.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 2.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

Review 3.  The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.

Authors:  Sonja M Best
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice.

Authors:  Yuki Takamatsu; Leo Uchida; Muhareva Raekiansyah; Mark Anthony Luz; Kouichi Morita; Daisuke Hayasaka
Journal:  Viruses       Date:  2018-02-03       Impact factor: 5.048

Review 5.  Viral Determinants of Virulence in Tick-Borne Flaviviruses.

Authors:  Eliza M Kellman; Danielle K Offerdahl; Wessam Melik; Marshall E Bloom
Journal:  Viruses       Date:  2018-06-16       Impact factor: 5.048

6.  Amino Acid Substitutions in NS5 Contribute Differentially to Tembusu Virus Attenuation in Ducklings and Cell Cultures.

Authors:  Xue Sun; Mengxu Sun; Lijiao Zhang; Ziding Yu; Jinxin Li; Wanying Xie; Jingliang Su
Journal:  Viruses       Date:  2021-05-16       Impact factor: 5.048

7.  Human Adenovirus Type 4 Comprises Two Major Phylogroups with Distinct Replicative Fitness and Virulence Phenotypes.

Authors:  Camden R Bair; Wei Zhang; Gabriel Gonzalez; Arash Kamali; Daniel Stylos; Jorge C G Blanco; Adriana E Kajon
Journal:  J Virol       Date:  2021-07-07       Impact factor: 6.549

8.  The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties.

Authors:  Sergei I Belikov; Ilya G Kondratov; Ulyana V Potapova; Galina N Leonova
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

9.  Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.

Authors:  Eun Kim; Geza Erdos; Shaohua Huang; Thomas Kenniston; Louis D Falo; Andrea Gambotto
Journal:  EBioMedicine       Date:  2016-10-03       Impact factor: 8.143

Review 10.  Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.

Authors:  Syed Z Shah; Basit Jabbar; Nadeem Ahmed; Anum Rehman; Hira Nasir; Sarooj Nadeem; Iqra Jabbar; Zia Ur Rahman; Shafiq Azam
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.